Education
About Us
Working with TipRanks
Follow Us
Procept Biorobotics Corp. (PRCT)
:PRCT
PRCT Analyst Ratings
Strong Buy
9 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PRCT Stock 12 Month Forecast
Average Price Target
$54.57
▲(70.96% Upside)
| Highest Price Target$65.00 | Average Price Target$54.57 | Lowest Price Target$50.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
$35→$31
Hold
-2.88%
Downside
Reiterated
11/06/25
AI Generated ArticleAI Generated Article
Truist Financial
$50
Buy
56.64%
Upside
Reiterated
11/05/25
Bank of America Securities
―
Buy
―
Reiterated
11/05/25
Wells Fargo
$58→$51
Buy
59.77%
Upside
Reiterated
11/05/25
TD Cowen
$85→$50
Buy
56.64%
Upside
Reiterated
11/05/25
Josh Jennings Reaffirms Buy Rating on PROCEPT BioRobotics Amid Strong Q3 Results and Conservative 2026 Forecast2:51 AM Procept BioRobotics Corp (NASDAQ: PRCT) Buy (1) ESG $50.00 (Prior $85.00) Report THE TD COWEN INSIGHT PRCT's stock is down 6% AH, likely in response to its decision to maintain its 2025 sales guidance and offer 2026 guidance that brackets the Street estimate at the high end. This reaction is excessive, in our view, especially since the stock is not priced to perfection. We think PRCT is simply being conservative. Still, we lower our PT to $50, which applies a 6 multiple to our 2026 sales estimate. The Q3 Results Were Strong: Q3 revenue totaled $83.3M, up 43% from last year and comfortably ahead of the Street's $80.8M forecast. US revenue $73.9M, a year-over-year improvement of 42%.
William Blair
―
Buy
―
Reiterated
11/05/25
Morgan Stanley
$62→$56
Buy
75.44%
Upside
Reiterated
11/05/25
BTIG
―
Hold
―
Reiterated
11/05/25
Piper Sandler
$55→$50
Buy
56.64%
Upside
Reiterated
11/05/25
Leerink Partners
$83→$65
Buy
103.63%
Upside
Reiterated
10/14/25
Oppenheimer
$60
Buy
87.97%
Upside
Upgraded
09/02/25
Stephens
$70
Buy
119.30%
Upside
Initiated
07/09/25
Jefferies
―
Hold
―
Reiterated
05/02/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
$35→$31
Hold
-2.88%
Downside
Reiterated
11/06/25
AI Generated ArticleAI Generated Article
Truist Financial
$50
Buy
56.64%
Upside
Reiterated
11/05/25
Bank of America Securities
―
Buy
―
Reiterated
11/05/25
Wells Fargo
$58→$51
Buy
59.77%
Upside
Reiterated
11/05/25
TD Cowen
$85→$50
Buy
56.64%
Upside
Reiterated
11/05/25
Josh Jennings Reaffirms Buy Rating on PROCEPT BioRobotics Amid Strong Q3 Results and Conservative 2026 Forecast2:51 AM Procept BioRobotics Corp (NASDAQ: PRCT) Buy (1) ESG $50.00 (Prior $85.00) Report THE TD COWEN INSIGHT PRCT's stock is down 6% AH, likely in response to its decision to maintain its 2025 sales guidance and offer 2026 guidance that brackets the Street estimate at the high end. This reaction is excessive, in our view, especially since the stock is not priced to perfection. We think PRCT is simply being conservative. Still, we lower our PT to $50, which applies a 6 multiple to our 2026 sales estimate. The Q3 Results Were Strong: Q3 revenue totaled $83.3M, up 43% from last year and comfortably ahead of the Street's $80.8M forecast. US revenue $73.9M, a year-over-year improvement of 42%.
William Blair
―
Buy
―
Reiterated
11/05/25
Morgan Stanley
$62→$56
Buy
75.44%
Upside
Reiterated
11/05/25
BTIG
―
Hold
―
Reiterated
11/05/25
Piper Sandler
$55→$50
Buy
56.64%
Upside
Reiterated
11/05/25
Leerink Partners
$83→$65
Buy
103.63%
Upside
Reiterated
10/14/25
Oppenheimer
$60
Buy
87.97%
Upside
Upgraded
09/02/25
Stephens
$70
Buy
119.30%
Upside
Initiated
07/09/25
Jefferies
―
Hold
―
Reiterated
05/02/25
Best Analysts Covering PROCEPT BioRobotics
1 Month
xxx
Success Rate
9/11 ratings generated profit
Average Return
+12.98%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 81.82% of your transactions generating a profit, with an average return of +12.98% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+11.68%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +11.68% per trade.
1 Year
Success Rate
13/25 ratings generated profit
Average Return
+22.90%
reiterated a buy rating 4 days ago
Copying Richard Newitter's trades and holding each position for 1 Year would result in 52.00% of your transactions generating a profit, with an average return of +22.90% per trade.
2 Years
xxx
Success Rate
11/25 ratings generated profit
Average Return
+3.32%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 44.00% of your transactions generating a profit, with an average return of +3.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PRCT Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
1
5
6
6
7
Buy
16
19
15
6
4
Hold
17
19
17
9
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
34
43
38
21
18
Each month's total comprises the sum of three months' worth of ratings.
PRCT Financial Forecast
PRCT Stock Forecast FAQ
What is PRCT’s average 12-month price target, according to analysts?
Based on analyst ratings, Procept Biorobotics Corp.’s 12-month average price target is 54.57.
What is PRCT’s upside potential, based on the analysts’ average price target?
Procept Biorobotics Corp. has 70.96% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PRCT a Buy, Sell or Hold?
Procept Biorobotics Corp. has a consensus rating of Strong Buy which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
What is Procept Biorobotics Corp.’s price target?
The average price target for Procept Biorobotics Corp. is 54.57. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $65.00 ,the lowest forecast is $50.00. The average price target represents 70.96% Increase from the current price of $31.92.
The highest analyst price target is $65.00 ,the lowest forecast is $50.00. The average price target represents 70.96% Increase from the current price of $31.92.
What do analysts say about Procept Biorobotics Corp.?
Procept Biorobotics Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of PRCT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.